Abstract
Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP) as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only preexisting vessels. This new view of GET may drive others to look at novel agents for treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 280-282 |
| Number of pages | 3 |
| Journal | Journal of Drugs in Dermatology |
| Volume | 16 |
| Issue number | 3 |
| State | Published - Mar 2017 |
| Externally published | Yes |